DERMASEAL

COMBINATION_PRODUCT2 trials

Sponsors

Vitruvian Medical Devices, Inc., Hobart W. Harris

Conditions

Foot Ulcer, DiabeticSkin Graft Complications

Phase 1

Study to Assess the Safety of DERMASEAL for Diabetic Foot Ulcers

Active, not recruitingNCT05586542

Vitruvian Medical Devices, Inc.Foot Ulcer, Diabetic

Start: 2022-10-03End: 2025-04-30Target: 26Updated: 2024-12-27

Study to Assess the Safety and Efficacy of DERMASEAL for the Treatment of Split-Thickness Skin Graft Donor Site Wounds

Not yet recruitingNCT06134843

Hobart W. HarrisSkin Graft Complications

Start: 2024-09-01End: 2025-04-15Target: 12Updated: 2024-06-11